Importance of Screening
- Identifies genetic predisposition to uterine and ovarian cancers.
- Enables doctors to establish intensive preventive surveillance plans.
- Provides vital information for family members regarding their genetic risks.
Book Lynch Syndrome Genetic Test | Lahalak Medical Platform
Discover your genetic risks early for a healthier future. Lynch Syndrome screening identifies gene mutations linked to endometrial cancer, empowering you with proactive preventive measures for yourself and your loved ones.
Scientific name: Lynch Syndrome (HNPCC) Genetic Screening
An advanced genetic test identifying mutations in MMR genes (MLH1, MSH2, MSH6, PMS2). It accurately assesses the inherited risk for endometrial and colorectal cancers, facilitating early prevention and monitoring.
Service type
Genetic Laboratory Test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Blood sample collection or buccal swab
- Gene sequencing (MLH1, MSH2, MSH6, PMS2)
- Detailed medical report
Medical Service Information
Who Should Get Tested
- Women with a family history of endometrial or colorectal cancers.
- Individuals diagnosed with uterine cancer before the age of 50.
- People with relatives known to have MMR gene mutations.
Genes Analyzed
- MLH1 Gene: Linked to significant risks of hereditary cancers.
- MSH2 & MSH6 Genes: Key genes in DNA mismatch repair.
- PMS2 Gene: Mutations increase the likelihood of hereditary tumor development.
Conditions & Notices
- Family medical history is recommended
- No dietary preparations required
Medical services you might also like
